Key Insights

Highlights

Treatment Research

4 treatments under study, led by Magnesium Sulfate

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Unknown3

Clinical Trials (3)

Showing 3 of 3 trials
NCT05520021Not ApplicableUnknownPrimary

The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat

NCT04644354Unknown

The Efficacy of Nifedipine in the Management of Preterm Labor

NCT03298191Phase 4UnknownPrimary

Tocolysis in Prevention of Preterm Labor

Showing all 3 trials

Research Network

Common Treatments

  • Magnesium Sulfate2
  • Nifedipine2
  • Ritodrine1
  • Calcium Channel Blockers1

Active Sponsors

  • Assiut University1
  • Ethem Unal, M.D., PhD, Associate Prof of Surgery & Surgic1
  • Konya Meram State Hospital1

Top Investigators

Related Conditions

  • Calciumchannel Blockers Toxicity1
  • Pregnancy Preterm1
  • Preterm Birth1
  • Preterm Labor1
  • Side Effect Of Drug1

Activity Timeline